ONTOLOGY REPORT - ANNOTATIONS
| Term: | N-methyl-4-phenylpyridinium |
|
| Accession: | CHEBI:641
|
browse the term
|
| Definition: | A pyridinium ion having a phenyl substituent at the 4-position. |
| Synonyms: | related_synonym: | 1-Methyl-4-phenylpyridinium; C12H12N; C[n+]1ccc(cc1)-c1ccccc1; Cyperquat; InChI=1S/C12H12N/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-10H,1H3/q+1; InChIKey=FMGYKKMPNATWHP-UHFFFAOYSA-N; N-Methyl-4-phenylpyridine; N-Methyl-4-phenylpyridinium ion |
| | xref_casrn: | 48134-75-4 |
| | xref: | Beilstein:1618932 "Beilstein Registry Number"; ChEMBL:212861 "ChEMBL COMPOUND"; ChemIDplus:48134-75-4 "CAS Registry Number"; Gmelin:329608 "Gmelin Registry Number"; KEGG COMPOUND:48134-75-4 "CAS Registry Number"; KEGG COMPOUND:C11310 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D015655 |
|
|
N-methyl-4-phenylpyridinium
|
| G |
Abcc5 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 5 |
|
increases expression |
ISO |
11 |
82,714,334 |
82,809,354 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
increases expression |
ISO |
8 |
124,305,097 |
124,313,887 |
RGD:6480464 |
CTD |
| G |
Acbd4 |
acyl-CoA binding domain containing 4 |
|
increases expression |
ISO |
10 |
92,276,972 |
92,285,988 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases activity |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
affects localization |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
multiple interactions |
ISO |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
multiple interactions |
EXP |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
affects localization |
EXP |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
multiple interactions |
EXP |
X |
134,868,878 |
134,908,166 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
decreases expression |
ISO |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Angptl2 |
angiopoietin-like 2 |
|
increases expression |
ISO |
3 |
12,226,515 |
12,256,396 |
RGD:6480464 |
CTD |
| G |
Angptl6 |
angiopoietin-like 6 |
|
increases expression |
ISO |
8 |
19,899,121 |
19,905,696 |
RGD:6480464 |
CTD |
| G |
Ankrd28 |
ankyrin repeat domain 28 |
|
increases expression |
ISO |
16 |
7,166,559 |
7,248,739 |
RGD:6480464 |
CTD |
| G |
Aqp4 |
aquaporin 4 |
|
multiple interactions |
ISO |
18 |
6,626,313 |
6,642,766 |
RGD:6480464 |
CTD |
| G |
Aqp4 |
aquaporin 4 |
|
affects response to substance |
ISO |
18 |
6,626,313 |
6,642,766 |
RGD:6480464 |
CTD |
| G |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
|
increases expression |
ISO |
18 |
30,893,720 |
30,916,965 |
RGD:6480464 |
CTD |
| G |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
|
increases expression |
ISO |
18 |
30,893,720 |
30,916,965 |
RGD:6480464 |
CTD |
| G |
Arhgdib |
Rho, GDP dissociation inhibitor (GDI) beta |
|
increases expression |
ISO |
4 |
173,967,842 |
173,986,494 |
RGD:6480464 |
CTD |
| G |
Arhgef2 |
rho/rac guanine nucleotide exchange factor (GEF) 2 |
|
increases expression |
ISO |
2 |
180,748,313 |
180,775,656 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
increases expression |
EXP |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Avpi1 |
arginine vasopressin-induced 1 |
|
increases expression |
ISO |
1 |
248,727,385 |
248,733,112 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
|
decreases expression |
ISO |
4 |
144,139,486 |
144,145,186 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
decreases expression |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
decreases expression |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
multiple interactions |
EXP |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
increases activity |
EXP |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
increases activity |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cblb |
Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
increases expression |
ISO |
11 |
49,690,402 |
49,856,762 |
RGD:6480464 |
CTD |
| G |
Cbs |
cystathionine beta synthase |
|
decreases expression |
EXP |
20 |
10,047,478 |
10,075,520 |
RGD:6480464 |
CTD |
| G |
Ccbl1 |
cysteine conjugate-beta lyase, cytoplasmic |
|
increases expression |
ISO |
3 |
9,195,737 |
9,209,545 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
decreases expression |
ISO |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Chac1 |
ChaC, cation transport regulator homolog 1 (E. coli) |
|
increases expression |
ISO |
3 |
105,869,762 |
105,873,332 |
RGD:6480464 |
CTD |
| G |
Clic4 |
chloride intracellular channel 4 |
|
increases expression |
ISO |
5 |
154,005,244 |
154,066,883 |
RGD:6480464 |
CTD |
| G |
Cln8 |
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
|
increases expression |
ISO |
16 |
79,569,745 |
79,579,636 |
RGD:6480464 |
CTD |
| G |
Cntnap1 |
contactin associated protein 1 |
|
increases expression |
ISO |
10 |
90,185,756 |
90,210,837 |
RGD:6480464 |
CTD |
| G |
Coasy |
CoA synthase |
|
increases expression |
ISO |
10 |
90,099,616 |
90,103,476 |
RGD:6480464 |
CTD |
| G |
Cox4i1 |
cytochrome c oxidase subunit IV isoform 1 |
|
increases expression |
ISO |
19 |
51,023,960 |
51,030,200 |
RGD:6480464 |
CTD |
| G |
Cox4i2 |
cytochrome c oxidase subunit IV isoform 2 (lung) |
|
increases expression |
ISO |
3 |
143,103,348 |
143,114,236 |
RGD:6480464 |
CTD |
| G |
Cryzl1 |
crystallin, zeta (quinone reductase)-like 1 |
|
increases expression |
ISO |
11 |
31,662,123 |
31,720,570 |
RGD:6480464 |
CTD |
| G |
Cth |
cystathionase (cystathionine gamma-lyase) |
|
increases expression |
ISO |
2 |
256,056,562 |
256,082,248 |
RGD:6480464 |
CTD |
| G |
Cyb5r1 |
cytochrome b5 reductase 1 |
|
increases expression |
ISO |
13 |
47,347,756 |
47,354,161 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
increases expression |
EXP |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
EXP |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
EXP |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
increases expression |
ISO |
1 |
156,447,588 |
156,478,740 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
decreases expression |
ISO |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf 1 homolog (Xenopus laevis) |
|
decreases expression |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
multiple interactions |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Drd3 |
dopamine receptor D3 |
|
decreases expression |
EXP |
11 |
58,446,901 |
58,520,589 |
RGD:6480464 |
CTD |
| G |
Drd3 |
dopamine receptor D3 |
|
multiple interactions |
EXP |
11 |
58,446,901 |
58,520,589 |
RGD:6480464 |
CTD |
| G |
Egln3 |
EGL nine homolog 3 (C. elegans) |
|
decreases expression |
ISO |
6 |
74,451,038 |
74,476,506 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
decreases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
multiple interactions |
EXP |
4 |
104,016,940 |
104,078,261 |
RGD:6480464 |
CTD |
| G |
Elovl7 |
ELOVL fatty acid elongase 7 |
|
increases expression |
ISO |
2 |
39,568,590 |
39,596,055 |
RGD:6480464 |
CTD |
| G |
En1 |
engrailed homeobox 1 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
En2 |
engrailed homeobox 2 |
|
decreases response to substance |
ISO |
4 |
2,469,889 |
2,475,729 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
decreases expression |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
decreases expression |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
multiple interactions |
EXP |
10 |
95,794,488 |
95,855,895 |
RGD:6480464 |
CTD |
| G |
Esco2 |
establishment of cohesion 1 homolog 2 (S. cerevisiae) |
|
decreases expression |
ISO |
15 |
45,239,871 |
45,254,898 |
RGD:6480464 |
CTD |
| G |
Fam162a |
family with sequence similarity 162, member A |
|
decreases expression |
ISO |
11 |
66,518,103 |
66,546,302 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fdxr |
ferredoxin reductase |
|
increases expression |
ISO |
10 |
105,342,684 |
105,351,374 |
RGD:6480464 |
CTD |
| G |
Fetub |
fetuin B |
|
increases expression |
ISO |
11 |
80,276,852 |
80,285,039 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
decreases expression |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
multiple interactions |
EXP |
15 |
37,115,068 |
37,155,652 |
RGD:6480464 |
CTD |
| G |
Flcn |
folliculin |
|
increases expression |
ISO |
10 |
46,110,527 |
46,129,613 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
decreases expression |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gdap1l1 |
ganglioside-induced differentiation-associated protein 1-like 1 |
|
increases expression |
ISO |
3 |
154,343,185 |
154,361,586 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
multiple interactions |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Ghrl |
ghrelin/obestatin prepropeptide |
|
decreases response to substance |
EXP |
4 |
149,622,566 |
149,628,111 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
increases expression |
ISO |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Gpi |
glucose-6-phosphate isomerase |
|
decreases expression |
ISO |
1 |
86,658,836 |
86,686,712 |
RGD:6480464 |
CTD |
| G |
Gpr19 |
G protein-coupled receptor 19 |
|
increases expression |
ISO |
4 |
171,791,727 |
171,809,215 |
RGD:6480464 |
CTD |
| G |
Gpr37 |
G protein-coupled receptor 37 |
|
increases expression |
ISO |
4 |
52,166,918 |
52,188,983 |
RGD:6480464 |
CTD |
| G |
Gprasp2 |
G protein-coupled receptor associated sorting protein 2 |
|
increases expression |
ISO |
X |
123,118,497 |
123,121,360 |
RGD:6480464 |
CTD |
| G |
Gpt2 |
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
|
increases expression |
ISO |
19 |
22,884,586 |
22,915,553 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gtpbp2 |
GTP binding protein 2 |
|
increases expression |
ISO |
9 |
10,377,808 |
10,385,845 |
RGD:6480464 |
CTD |
| G |
Hcrtr2 |
hypocretin (orexin) receptor 2 |
|
increases expression |
ISO |
8 |
81,068,303 |
81,196,608 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hk2 |
hexokinase 2 |
|
decreases expression |
ISO |
4 |
116,925,725 |
116,975,211 |
RGD:6480464 |
CTD |
| G |
Hmgcl |
3-hydroxymethyl-3-methylglutaryl-CoA lyase |
|
increases expression |
ISO |
5 |
154,730,232 |
154,743,974 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
decreases response to substance |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hsd17b8 |
hydroxysteroid (17-beta) dehydrogenase 8 |
|
increases expression |
ISO |
20 |
4,964,860 |
4,966,855 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases response to substance |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
|
increases expression |
ISO |
7 |
140,885,388 |
140,890,028 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Kdm3a |
lysine (K)-specific demethylase 3A |
|
decreases expression |
ISO |
4 |
104,866,501 |
104,911,355 |
RGD:6480464 |
CTD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
increases expression |
ISO |
5 |
148,707,505 |
148,718,296 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
decreases expression |
ISO |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
decreases expression |
ISO |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Lonp1 |
lon peptidase 1, mitochondrial |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
|
increases expression |
ISO |
4 |
127,975,386 |
128,597,119 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
multiple interactions |
ISO |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases phosphorylation |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases activity |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases activity |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases activity |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
increases expression |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
3 |
155,985,473 |
155,993,433 |
RGD:6480464 |
CTD |
| G |
Mmrn2 |
multimerin 2 |
|
increases expression |
ISO |
16 |
10,031,365 |
10,052,169 |
RGD:6480464 |
CTD |
| G |
Mt-cyb |
mitochondrially encoded cytochrome b |
|
decreases expression |
ISO |
MT |
14,136 |
15,278 |
RGD:6480464 |
CTD |
| G |
Mt-nd1 |
mitochondrially encoded NADH dehydrogenase 1 |
|
multiple interactions |
ISO |
MT |
2,740 |
3,694 |
RGD:6480464 |
CTD |
| G |
Mt-nd4 |
mitochondrially encoded NADH dehydrogenase 4 |
|
decreases expression |
ISO |
MT |
10,160 |
11,537 |
RGD:6480464 |
CTD |
| G |
Mthfr |
methylenetetrahydrofolate reductase (NAD(P)H) |
|
increases expression |
ISO |
5 |
165,112,850 |
165,126,885 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nagk |
N-acetylglucosamine kinase |
|
increases expression |
ISO |
4 |
117,989,937 |
117,997,260 |
RGD:6480464 |
CTD |
| G |
Ndufa4l2 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
|
decreases expression |
ISO |
7 |
67,492,198 |
67,494,324 |
RGD:6480464 |
CTD |
| G |
Ndufs4 |
NADH dehydrogenase (ubiquinone) Fe-S protein 4 |
|
increases response to substance |
ISO |
2 |
45,839,236 |
46,479,619 |
RGD:6480464 |
CTD |
| G |
Ndufv3 |
NADH dehydrogenase (ubiquinone) flavoprotein 3 |
|
decreases expression |
ISO |
20 |
9,951,109 |
9,960,265 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases response to substance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases localization |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfu1 |
NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae) |
|
increases expression |
ISO |
4 |
121,184,017 |
121,187,110 |
RGD:6480464 |
CTD |
| G |
Ninj1 |
ninjurin 1 |
|
increases expression |
ISO |
17 |
21,410,701 |
21,419,472 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
decreases activity |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
increases expression |
ISO |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Ogdh |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
|
decreases activity |
ISO |
14 |
87,022,994 |
87,090,768 |
RGD:6480464 |
CTD |
| G |
Ogdh |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
|
multiple interactions |
ISO |
14 |
87,022,994 |
87,090,768 |
RGD:6480464 |
CTD |
| G |
Oprl1 |
opiate receptor-like 1 |
|
decreases expression |
EXP |
3 |
170,869,862 |
170,873,417 |
RGD:6480464 |
CTD |
| G |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
|
increases expression |
ISO |
10 |
87,403,919 |
87,411,058 |
RGD:6480464 |
CTD |
| G |
Otx2 |
orthodenticle homeobox 2 |
|
decreases response to substance |
ISO |
15 |
24,622,851 |
24,632,435 |
RGD:6480464 |
CTD |
| G |
P2rx4 |
purinergic receptor P2X, ligand-gated ion channel 4 |
|
increases expression |
ISO |
12 |
34,943,900 |
34,961,551 |
RGD:6480464 |
CTD |
| G |
P4ha1 |
prolyl 4-hydroxylase, alpha polypeptide I |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Pbxip1 |
pre-B-cell leukemia homeobox interacting protein 1 |
|
increases expression |
ISO |
2 |
181,637,864 |
181,647,769 |
RGD:6480464 |
CTD |
| G |
Pfkl |
phosphofructokinase, liver |
|
decreases expression |
ISO |
20 |
11,009,359 |
11,032,511 |
RGD:6480464 |
CTD |
| G |
Pfkl |
phosphofructokinase, liver |
|
decreases expression |
ISO |
20 |
11,009,359 |
11,032,511 |
RGD:6480464 |
CTD |
| G |
Pgam1 |
phosphoglycerate mutase 1 (brain) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pgam1 |
phosphoglycerate mutase 1 (brain) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
decreases expression |
ISO |
X |
94,324,219 |
94,340,193 |
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
decreases expression |
ISO |
X |
94,324,219 |
94,340,193 |
RGD:6480464 |
CTD |
| G |
Pink1 |
PTEN induced putative kinase 1 |
|
affects response to substance |
ISO |
5 |
157,091,181 |
157,103,293 |
RGD:6480464 |
CTD |
| G |
Pink1 |
PTEN induced putative kinase 1 |
|
multiple interactions |
ISO |
5 |
157,091,181 |
157,103,293 |
RGD:6480464 |
CTD |
| G |
Pink1 |
PTEN induced putative kinase 1 |
|
increases response to substance |
ISO |
5 |
157,091,181 |
157,103,293 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
decreases expression |
ISO |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
decreases expression |
ISO |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Pkn1 |
protein kinase N1 |
|
increases expression |
ISO |
19 |
26,132,497 |
26,160,471 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases expression |
ISO |
13 |
64,135,729 |
64,280,815 |
RGD:6480464 |
CTD |
| G |
Plcb3 |
phospholipase C, beta 3 (phosphatidylinositol-specific) |
|
increases expression |
ISO |
1 |
209,628,425 |
209,643,694 |
RGD:6480464 |
CTD |
| G |
Plcd3 |
phospholipase C, delta 3 |
|
increases expression |
ISO |
10 |
92,234,651 |
92,275,433 |
RGD:6480464 |
CTD |
| G |
Pnoc |
prepronociceptin |
|
decreases expression |
EXP |
15 |
44,822,635 |
44,835,637 |
RGD:6480464 |
CTD |
| G |
Pnoc |
prepronociceptin |
|
increases expression |
EXP |
15 |
44,822,635 |
44,835,637 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
multiple interactions |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppfibp2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
|
decreases expression |
ISO |
1 |
164,979,709 |
165,125,077 |
RGD:6480464 |
CTD |
| G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
|
decreases expression |
ISO |
7 |
46,876,552 |
46,986,022 |
RGD:6480464 |
CTD |
| G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
increases expression |
ISO |
1 |
95,994,023 |
95,997,080 |
RGD:6480464 |
CTD |
| G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
|
increases expression |
ISO |
1 |
95,994,023 |
95,997,080 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
decreases expression |
EXP |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
decreases expression |
EXP |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prdx4 |
peroxiredoxin 4 |
|
multiple interactions |
EXP |
X |
61,501,206 |
61,516,286 |
RGD:6480464 |
CTD |
| G |
Prdx5 |
peroxiredoxin 5 |
|
decreases expression |
EXP |
1 |
209,583,414 |
209,586,399 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
decreases expression |
EXP |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
increases expression |
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prrc2c |
proline-rich coiled-coil 2C |
|
increases expression |
ISO |
13 |
78,332,572 |
78,400,635 |
RGD:6480464 |
CTD |
| G |
Psd |
pleckstrin and Sec7 domain containing |
|
increases expression |
ISO |
1 |
251,527,890 |
251,542,740 |
RGD:6480464 |
CTD |
| G |
Psph |
phosphoserine phosphatase |
|
increases expression |
ISO |
12 |
27,969,748 |
27,984,318 |
RGD:6480464 |
CTD |
| G |
Ptgir |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
increases expression |
ISO |
1 |
77,234,538 |
77,236,921 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases phosphorylation |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbm3 |
RNA binding motif (RNP1, RRM) protein 3 |
|
decreases expression |
ISO |
X |
26,379,303 |
26,382,739 |
RGD:6480464 |
CTD |
| G |
Reep6 |
receptor accessory protein 6 |
|
increases expression |
ISO |
7 |
10,885,266 |
10,891,936 |
RGD:6480464 |
CTD |
| G |
Rest |
RE1-silencing transcription factor |
|
affects localization |
ISO |
14 |
33,136,046 |
33,151,142 |
RGD:6480464 |
CTD |
| G |
Rest |
RE1-silencing transcription factor |
|
affects response to substance |
ISO |
14 |
33,136,046 |
33,151,142 |
RGD:6480464 |
CTD |
| G |
Rest |
RE1-silencing transcription factor |
|
increases expression |
ISO |
14 |
33,136,046 |
33,151,142 |
RGD:6480464 |
CTD |
| G |
Rgl3 |
ral guanine nucleotide dissociation stimulator-like 3 |
|
increases expression |
ISO |
8 |
21,072,473 |
21,092,569 |
RGD:6480464 |
CTD |
| G |
Ric8a |
resistance to inhibitors of cholinesterase 8 homolog A (C. elegans) |
|
increases expression |
ISO |
1 |
201,014,483 |
201,020,790 |
RGD:6480464 |
CTD |
| G |
Rit1 |
Ras-like without CAAX 1 |
|
increases expression |
ISO |
2 |
180,846,683 |
180,859,135 |
RGD:6480464 |
CTD |
| G |
Rnd1 |
Rho family GTPase 1 |
|
increases expression |
ISO |
7 |
137,418,519 |
137,425,590 |
RGD:6480464 |
CTD |
| G |
Rnf7 |
ring finger protein 7 |
|
decreases response to substance |
ISO |
8 |
101,534,827 |
101,543,837 |
RGD:6480464 |
CTD |
| G |
Rnf7 |
ring finger protein 7 |
|
multiple interactions |
ISO |
8 |
101,534,827 |
101,543,837 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
decreases expression |
ISO |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
increases expression |
ISO |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
decreases expression |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases expression |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
EXP |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Slc12a4 |
solute carrier family 12 (potassium/chloride transporters), member 4 |
|
increases expression |
ISO |
19 |
35,785,181 |
35,807,024 |
RGD:6480464 |
CTD |
| G |
Slc16a3 |
solute carrier family 16, member 3 (monocarboxylic acid transporter 4) |
|
decreases expression |
ISO |
10 |
110,159,679 |
110,163,182 |
RGD:6480464 |
CTD |
| G |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
|
multiple interactions |
ISO |
16 |
22,356,304 |
22,389,827 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
multiple interactions |
ISO |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
increases uptake |
ISO |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
multiple interactions |
EXP |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
multiple interactions |
EXP |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
increases uptake |
EXP |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
increases import |
ISO |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
multiple interactions |
ISO |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
increases uptake |
ISO |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
multiple interactions |
ISO |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
increases uptake |
ISO |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
multiple interactions |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
multiple interactions |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
increases uptake |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
multiple interactions |
EXP |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
increases import |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
multiple interactions |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
increases uptake |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
multiple interactions |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
increases uptake |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
increases uptake |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
decreases uptake |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
increases uptake |
ISO |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
increases uptake |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
EXP |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
increases uptake |
EXP |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
increases uptake |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
increases uptake |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
increases uptake |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
increases uptake |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
increases uptake |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
affects uptake |
ISO |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
increases transport |
EXP |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
increases transport |
EXP |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
EXP |
1 |
42,690,158 |
42,781,895 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
increases uptake |
EXP |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc25a14 |
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
|
increases expression |
ISO |
X |
135,035,550 |
135,073,837 |
RGD:6480464 |
CTD |
| G |
Slc25a14 |
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
|
multiple interactions |
ISO |
X |
135,035,550 |
135,073,837 |
RGD:6480464 |
CTD |
| G |
Slc25a14 |
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
|
decreases response to substance |
ISO |
X |
135,035,550 |
135,073,837 |
RGD:6480464 |
CTD |
| G |
Slc25a27 |
solute carrier family 25, member 27 |
|
increases expression |
ISO |
9 |
13,002,823 |
13,028,534 |
RGD:6480464 |
CTD |
| G |
Slc25a27 |
solute carrier family 25, member 27 |
|
affects response to substance |
ISO |
9 |
13,002,823 |
13,028,534 |
RGD:6480464 |
CTD |
| G |
Slc25a33 |
solute carrier family 25 (pyrimidine nucleotide carrier), member 33 |
|
increases expression |
ISO |
5 |
166,836,557 |
166,861,525 |
RGD:6480464 |
CTD |
| G |
Slc29a4 |
solute carrier family 29 (nucleoside transporters), member 4 |
|
affects uptake |
EXP |
12 |
12,241,259 |
12,251,656 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases expression |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc47a1 |
solute carrier family 47, member 1 |
|
decreases activity |
ISO |
10 |
47,514,258 |
47,548,353 |
RGD:6480464 |
CTD |
| G |
Slc47a1 |
solute carrier family 47, member 1 |
|
increases transport |
EXP |
10 |
47,514,258 |
47,548,353 |
RGD:6480464 |
CTD |
| G |
Slc48a1 |
solute carrier family 48 (heme transporter), member 1 |
|
increases expression |
ISO |
7 |
136,492,421 |
136,500,222 |
RGD:6480464 |
CTD |
| G |
Slc50a1 |
solute carrier family 50 (sugar transporter), member 1 |
|
increases expression |
ISO |
2 |
181,440,905 |
181,443,285 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
multiple interactions |
ISO |
19 |
15,098,281 |
15,139,898 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
affects response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases uptake |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases response to substance |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
increases expression |
ISO |
5 |
138,300,869 |
138,334,893 |
RGD:6480464 |
CTD |
| G |
Slc7a3 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 |
|
increases expression |
ISO |
X |
89,159,603 |
89,164,314 |
RGD:6480464 |
CTD |
| G |
Slc7a5 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
|
increases expression |
ISO |
19 |
52,120,728 |
52,149,332 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
affects response to substance |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases response to substance |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
affects response to substance |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
affects response to substance |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases response to substance |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Stbd1 |
starch binding domain 1 |
|
increases expression |
ISO |
14 |
17,031,752 |
17,035,157 |
RGD:6480464 |
CTD |
| G |
Stx4 |
syntaxin 4 |
|
increases expression |
ISO |
1 |
187,125,847 |
187,132,932 |
RGD:6480464 |
CTD |
| G |
Tbc1d9b |
TBC1 domain family, member 9B (with GRAM domain) |
|
increases expression |
ISO |
10 |
35,686,754 |
35,721,323 |
RGD:6480464 |
CTD |
| G |
Tbxas1 |
thromboxane A synthase 1, platelet |
|
decreases expression |
ISO |
4 |
66,502,253 |
66,677,538 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases activity |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tiam2 |
T-cell lymphoma invasion and metastasis 2 |
|
increases expression |
ISO |
1 |
38,479,385 |
38,514,359 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
decreases response to substance |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
decreases expression |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases acetylation |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
decreases expression |
ISO |
4 |
160,933,341 |
160,936,871 |
RGD:6480464 |
CTD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
ISO |
3 |
142,664,641 |
142,670,135 |
RGD:6480464 |
CTD |
| G |
Trip10 |
thyroid hormone receptor interactor 10 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
affects response to substance |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
multiple interactions |
EXP |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txn2 |
thioredoxin 2 |
|
increases oxidation |
ISO |
7 |
115,833,695 |
115,847,690 |
RGD:6480464 |
CTD |
| G |
Txn2 |
thioredoxin 2 |
|
multiple interactions |
EXP |
7 |
115,833,695 |
115,847,690 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
decreases expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Ubl4b |
ubiquitin-like 4B |
|
increases expression |
ISO |
2 |
203,107,245 |
203,110,347 |
RGD:6480464 |
CTD |
| G |
Wdr5b |
WD repeat domain 5B |
|
increases expression |
ISO |
11 |
66,546,008 |
66,547,867 |
RGD:6480464 |
CTD |
| G |
Wdr67 |
WD repeat domain 67 |
|
increases expression |
ISO |
7 |
94,615,000 |
94,676,965 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
decreases response to substance |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
| G |
Zzef1 |
zinc finger, ZZ-type with EF hand domain 1 |
|
increases expression |
ISO |
10 |
59,683,159 |
59,822,123 |
RGD:6480464 |
CTD |
Term paths to the root
|